30
NVO - $48 True Value
Novo Nordisk A/S is a global healthcare company engaged in diabetes care. The Company is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The Company operates through two business segments: diabetes and obesity care, and biopharmaceuticals. The Company's diabetes and obesity care segment covers insulin, GLP-1, other protein-related products, such as glucagon, protein-related delivery systems and needles, and oral anti-diabetic drugs.
Stage 4 Decline – Excellent Video of the Breakdown of recent earnings report
Would you like to take your trading to the next level. Take 52 trades with GP over the next 12 months , as he breaks down each step of trading into easy-to-understand language .
Join the Premium Trade of the Week with GP and Master the Money Flow.
Subscribe to The Money Flow Trading Society Newsletter and Trade Updates
Made with FlippingBook - professional solution for displaying marketing and sales documents online